9,803,922 Shares Liquidia Corporation UNDERWRITING AGREEMENTUnderwriting Agreement • April 18th, 2022 • Liquidia Corp • Pharmaceutical preparations • New York
Contract Type FiledApril 18th, 2022 Company Industry JurisdictionIntroductory. Liquidia Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 9,803,922 shares of its common stock, par value $0.001 per share (the “Shares”). The 9,803,922 Shares to be sold by the Company are called the “Firm Shares.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional 1,470,588 Shares as provided in Section 2. The additional 1,470,588 Shares to be sold by the Company pursuant to such option are collectively called the “Optional Shares.” The Firm Shares and, if and to the extent such option is exercised, the Optional Shares are collectively called the “Offered Shares.” BofA Securities, Inc. (“BofA”) has agreed to act as representative of the several Underwriters (in such capacity, the “Representative”) in connection with the offering and sale of the Offered Shares. To the extent there are no additional underwriter